Dalton Pharma Services Business Strategy
Since its founding in 1986, Dalton Pharma Services has grown to become a leading pharmaceutical services company, providing discovery, development and manufacturing support to our global customer base.
Dalton Pharma Services Business Strategy strategy has always been to provide world class scientific services to our customers, with a focus on quality and innovation.
The company began operations in a small lab at York University in 1986, primarily focusing on meeting the chemical needs of local researchers, including hard-to-find or difficult chemical synthesis products. The company became known for its strong chemistry expertise and expanded both its operational lab footprint as well as its customer base. With the provision of larger scale chemical synthesis, Dalton made a strategic decision to add cGMP manufacturing capabilities to support the demand of its customers.
By 2000, Dalton had outgrown its operational space and moved to its current 42,000 square foot (3,900 square meter) facility in Toronto. This additional space allowed Dalton to strategically invest in adding more comprehensive lab services, formulation development services, finished dose manufacturing (including sterile injectables) and large scale chemistry and research capabilities.
The objective is to focus on offering pharmaceutical services that meet our customer's evolving needs and add value by making their supply choices simpler. Today Dalton boasts a fully integrated service offering everything from discovery and research all the way through to small scale cGMP commercial manufacturing. We Discover, Develop, and Manufacture.